October 31, 2012
Mochida Pharmaceutical and Mitsubishi Tanabe Pharma Corporation (MTPC) have seen signs of sales growth for the antidepressant Lexapro (escitalopram), comarketed by the two companies, since the lifting of its long-term prescription ban in August. Lexapro sales, which remained rather tepid...read more